Key result
Myocarditis may unmask occult genetic mutations like MYL2, requiring individualized return-to-play decisions in young athletes.
Why the study?
Myocarditis and inherited cardiomyopathies are important causes of malignant arrhythmias in young athletes, with challenges in risk stratification and return-to-play decisions in genotype-positive individuals.
Case Report (n=1)
Myocarditis may unmask occult genetic substrates, highlighting the need for individualized shared decision-making for return-to-play in genotype-positive athletes.
Answers are grounded in this paper and cite their sources.
Warrants genetic evaluation to inform return-to-play decisions in young athletes with myocarditis; extends understanding of gene-environment interactions in inherited heart disease.
BACKGROUND: Myocarditis and inherited cardiomyopathies are important causes of malignant arrhythmias in young athletes. CASE SUMMARY: A 23-year-old female competitive soccer player presented with exertional chest discomfort, dizziness, and syncope. Troponin elevation and cardiac magnetic resonance with subepicardial late gadolinium enhancement of the inferolateral wall were thought to be consistent with acute myocarditis. She recovered after activity restriction and had normal follow-up magnetic resonance imaging, echocardiogram, and cardiopulmonary exercise testing. During monitored return to play, she developed a 42-second episode of polymorphic ventricular tachycardia while sprinting, leading to subcutaneous implantable cardioverter-defibrillator placement for secondary prevention. Genetic testing revealed a pathogenic MYL2 variant; her mother, brother, and sister carry the same mutation. DISCUSSION: This case highlights the overlap between myocarditis, genetic susceptibility, and exercise-triggered polymorphic ventricular tachycardia, and the challenges of risk stratification and return-to-play decisions in genotype-positive athletes with prior malignant arrhythmia. TAKE-HOME MESSAGE: Myocarditis may unmask occult genetic substrates, and return-to-play decisions require individualized shared decision-making in the context of incomplete risk data.
No takes yet. Share an insight, caveat, or question.
Burka et al. (2026) conducted a case report in Ventricular Tachycardia, Myocarditis, MYL2 mutation (n=1). MYL2 mutation and prior myocarditis was evaluated on Polymorphic ventricular tachycardia. A 23-year-old female athlete with prior myocarditis and a pathogenic MYL2 variant developed exercise-triggered polymorphic ventricular tachycardia, requiring a subcutaneous ICD.
Synapse has enriched 10 related papers. Consider them for comparative context: